JP2023554692A5 - - Google Patents
Info
- Publication number
- JP2023554692A5 JP2023554692A5 JP2023542924A JP2023542924A JP2023554692A5 JP 2023554692 A5 JP2023554692 A5 JP 2023554692A5 JP 2023542924 A JP2023542924 A JP 2023542924A JP 2023542924 A JP2023542924 A JP 2023542924A JP 2023554692 A5 JP2023554692 A5 JP 2023554692A5
- Authority
- JP
- Japan
- Prior art keywords
- cyclobenzaprine hcl
- combination according
- eutectic
- weight
- mannitol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063122469P | 2020-12-07 | 2020-12-07 | |
| US63/122,469 | 2020-12-07 | ||
| PCT/US2021/062244 WO2022125572A1 (en) | 2020-12-07 | 2021-12-07 | Cyclobenzaprine treatment for fibromyalgia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023554692A JP2023554692A (ja) | 2023-12-28 |
| JP2023554692A5 true JP2023554692A5 (https=) | 2024-12-17 |
Family
ID=79686930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023542924A Pending JP2023554692A (ja) | 2020-12-07 | 2021-12-07 | 線維筋痛症のためのシクロベンザプリン処置 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20240024256A1 (https=) |
| EP (1) | EP4255407A1 (https=) |
| JP (1) | JP2023554692A (https=) |
| CN (1) | CN116940340A (https=) |
| AU (1) | AU2021396509A1 (https=) |
| CA (1) | CA3204202A1 (https=) |
| IL (1) | IL303497A (https=) |
| MX (1) | MX2023006720A (https=) |
| WO (1) | WO2022125572A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3260042A1 (en) * | 2022-06-21 | 2023-12-28 | Tonix Pharmaceuticals Holding Corp. | CYCLOBENZAPRINE TREATMENT FOR POST-ACUTE SEQUELAE OF A (SARS)-COV-2 (PASC) INFECTION |
| WO2025137348A1 (en) * | 2023-12-19 | 2025-06-26 | Tonix Pharmaceuticals Holding Corp. | Cyclobenzaprine hcl for use in treating fibromyalgia with early onset response and favorable tolerability and side effect profile |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS63822B1 (sr) | 2012-06-15 | 2023-01-31 | Tonix Pharma Holdings Ltd | Kompozicije i postupci za transmukoznu apsorpciju |
| SMT202400324T1 (it) | 2013-03-15 | 2024-11-15 | Tonix Pharma Ltd | Formulazioni eutettiche di ciclobenzaprina cloridrato e mannitolo |
| MY186047A (en) * | 2014-09-18 | 2021-06-17 | Tonix Pharma Holdings Ltd | Eutectic formulations of cyclobenzaprine hydrochloride |
| US20220117915A1 (en) * | 2018-08-20 | 2022-04-21 | Tonix Pharma Holdings Limited | Methods of treating acute stress disorder and posttraumatic stress disorder |
-
2021
- 2021-12-07 US US18/265,525 patent/US20240024256A1/en active Pending
- 2021-12-07 EP EP21844438.8A patent/EP4255407A1/en active Pending
- 2021-12-07 IL IL303497A patent/IL303497A/en unknown
- 2021-12-07 MX MX2023006720A patent/MX2023006720A/es unknown
- 2021-12-07 JP JP2023542924A patent/JP2023554692A/ja active Pending
- 2021-12-07 AU AU2021396509A patent/AU2021396509A1/en active Pending
- 2021-12-07 CN CN202180089897.8A patent/CN116940340A/zh active Pending
- 2021-12-07 WO PCT/US2021/062244 patent/WO2022125572A1/en not_active Ceased
- 2021-12-07 CA CA3204202A patent/CA3204202A1/en active Pending
-
2025
- 2025-12-16 US US19/421,039 patent/US20260108477A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Strollo Jr et al. | Solriamfetol for the treatment of excessive sleepiness in OSA: a placebo-controlled randomized withdrawal study | |
| JP2015519404A5 (https=) | ||
| JP2023554692A5 (https=) | ||
| KR20080059208A (ko) | 수면 호흡 장애를 예방 및 치료하는 방법과 그 수단 | |
| TW202341995A (zh) | 用於治療cns相關病症之神經活性類固醇 | |
| AU2022202218A1 (en) | Combination Therapy Using Acamprosate And D-Cycloserine | |
| TW202019400A (zh) | 治療急性壓力症候群及創傷後壓力症候群之方法 | |
| US20240285643A1 (en) | Treating influenza using substituted polycyclic pyridone derivatives and prodrugs thereof in a subject having influenza and a severe influenza condition | |
| JPWO2007046347A1 (ja) | 筋萎縮性側索硬化症患者の運動神経保護用医薬 | |
| JP2023554692A (ja) | 線維筋痛症のためのシクロベンザプリン処置 | |
| JP2023543439A5 (https=) | ||
| JP2023537369A5 (https=) | ||
| Ho et al. | Effects of a novel disc formulation on dry mouth symptoms and enamel remineralization in patients with hyposalivation: an in vivo study | |
| Yanagihara et al. | Treatment of obstructive sleep apnea with a tongue-stabilizing device at a single multidisciplinary sleep center | |
| JP2021530568A5 (https=) | ||
| WO2023250036A1 (en) | Cyclobenzaprine treatment for post-acute sequelae of (sars)-cov-2 infection (pasc) | |
| Arhakis et al. | The young dental patient with systemic disease | |
| US8652463B1 (en) | Dietary supplement to reduce the occurrence of migraines and treat their symptoms | |
| US11826326B2 (en) | Benzoic acid or a salt and derivative thereof for use in preventing or treating depression | |
| Yonkers et al. | Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder | |
| US20250228808A1 (en) | Compositions and methods for the treatment of coronavirus diseases | |
| US20250152537A1 (en) | Compositions and methods for the treatment of human immunodeficiency virus | |
| Thomas et al. | Medications affecting outcomes and prognosis of dental treatment: part 1 | |
| JPH04112823A (ja) | 痴呆治療剤 | |
| JP2023532315A (ja) | 気分調整促進剤として使用される組成物 |